Dr. Jack Barkin MD, Urologist. TORONTO Credentials Clinical Professor: Department of Surgery, University of Toronto Associate Professor, Division of Urology, University of Toronto Executive Editor-in-Chief: Canadian Journal of Urology Medical Director: Can-Am HIFU, HIFU Proctor Past Chief of Staff: Humber River Hospital, Toronto Director: Society of Urologic Surgeons of Ontario Vice President: Canadian Society for the Study of the Aging Male Board: Canadian Male Sexual Health Council Education and Memberships Dr. Barkin graduated with honours from medical school at the University of Toronto. He served on numerous medical advisory boards and has been published extensively in medical and urology journals with over 80 peer reviewed articles. He reviews articles for numerous other urologic journals as well as reviewing abstract submissions for many International Urologic meetings. He is a Fellow of the American College of Surgeons (FACS), a Fellow of the Royal College of Surgeons of Canada (FRCS), a Fellow of the International College of Surgeons (FICS) and a Diplomate of the American Board of Urology (DABU). He has a Masters in Health Care Management and is one of a few Certified Canadian Physician Executives. In 2012 he spearheaded the development of the Robotic Surgical Program at Humber River Hospital. Clinical and Research Interests Dr. Barkin has been involved in clinical research for over 25 years and has been the principal investigator in over 250 Canadian and international clinical drug trials. Dr. Barkin is a world-renowned expert on sexual dysfunction. He launched Viagra, Levitra, Cialis, Androgel, Casodex, and other pharmaceuticals in Canada. His clinical and research interests include erectile dysfunction, prostate diseases-benign and malignant, male menopause, bladder cancer and new urologic technology and techniques. Dr. Barkin has given over 1,000 presentations and lectures worldwide including those in Russia, Malaysia, China, The Middle East, Europe, Indonesia, The Phillipines, Korea, Cambodia, Africa and South America and Mexico as well as extensively in the United States and Canada. He has participated as faculty in countless medical symposia at the undergraduate and post graduate levels and been the Visiting Professor at many Universities throughout the world. Clinical Expertise

Dr. Jack Barkin MD, Urologist. TORONTO  Is in good standing with the College of Physicians and Surgeons of Canada, Dr. Jack Barkin MD, Urologist. TORONTO is in good standing with the Canadian Urological Society and the Canadian Medical Association

Keywords: Benign Prostatic Hypertrophy, Benign prostatic hyperplasia (BPH) , Colon Cancer Screening & Treatment , Prostate Cancer, Hypothyroidism, Laparoscopic Surgery, Obesity Prostate Cancer treatment 

Dr. Jack Barkin MD, Urologist. TORONTO

If you are looking for local services or  treatment  from your Local Urologist in the office or hospital from a Local Urologist, contact a provider such as ( Dr. Jack Barkin Barkin ) to inquire if they are accepting patients or you need a referral.   Phone number to book an appointment 14169799000

The speaker in the video may have no association with ( Dr. Jack Barkin Barkin, Local Urologist Toronto, ON ). 
( Dr. Jack Barkin Barkin, Local Urologist Toronto, ON ), may talk about some of the conditions and some of the treatment options shown on the videos. Always talk with your Local Urologist about the information you learnt from the videos in regards to treatments and procedures the Local Urologist could  perform and if they would be appropriate for you. Remember good information is the corner stone to understanding your condition or disease. Please contact ( Dr. Jack Barkin Barkin, Local Urologist Toronto, ON ) to enquire if this health care provider is accepting new patients. Prostate Cancer NOW is part of the Now Health Network and its focus is on muscular and skeletal  conditions

Urology Information: 

Depending on the case, prostate cancer may be safely followed with active surveillance or watchful waiting rather than surgery, chemotherapy or radiation. Ask your local urologist for more information on Contino®, an alternative to diapers or surgery. Patients may be referred to a urologist if their physician suspects they may need treatment for a condition relating to bladder, urethra, ureters, kidneys, and adrenal glands.

Urethral inserts like Contino® are temporarily inserted into the urethra (the tube which carries urine to the outside of the body) to prevent or reduce bladder leakage. Depending on the case, prostate cancer may be safely followed with active surveillance or watchful waiting rather than surgery, chemotherapy or radiation. Prostate cancer is the most common cancer in Canadian men. It is most common in older men

Colorectal ; Other Cancers: Dietary fibre and antioxidant intake are two of the biggest considerations
when it comes to reducing the risk of preventable cancers, such as colorectal cancer. Beets and beet
greens are among the most abundant sources of both these important nutrients.

Your body will digest and absorb short-chain carbohydrates (also called rapid-acting carbohydrates) more quickly, which can actually cause a spike in the blood sugar. Some examples would be juice, white bread and sugar. Longer-chain carbohydrates take the body longer to digest and absorb, causing less of an effect on the blood sugar. Examples are legumes, oats, barley and berries. These carbohydrates can play a very important role in diabetes management. 

Surgery for prostate cancer is called a radical prostatectomy and involves the removal of the prostate gland with or without some lymph nodes in the pelvis. This can be performed with key-hole surgery called laparoscopy (usually done with a robot to help the surgeon) or through a small incision in the lower part of the abdomen called open surgery.

Once prostate cancer is diagnosed, one of the first things doctors do is determine how aggressive cancers are (also known as tumor grade) and how much of the prostate is involved and if the cancer has spread outside of the gland to nearby tissues or other parts of the body (otherwise known as tumor stage). This information is important to help determine the treatment options for men newly diagnosed with prostate cancer. What is tumor Grade?:

When a tumor is discovered on prostate biopsy, the aggressiveness of the cancer can be classified into a category called tumor grade. In general, the higher the grade, the more aggressive cancers are. In prostate cancer, the grade is most commonly described as a Gleason Score. The Gleason Score of a prostate cancer is between 2-10. Scores 6 or less are considered mildly aggressive, 7 is considered intermediate aggressive, and scores 8-10 are considered very aggressive. In summary, the higher the Gleason Score, the more aggressive the cancer is, and the greater the risk of cancer spreading outside of the prostate gland. What is tumor Stage?: Often seeing a local urologist in Toronto can help.